Advertisement
Frazier Lifesciences Acqu... (FLACU)
NASDAQ: FLACU
· Real-Time Price · USD
9.50
0.23 (2.48%)
At close: Nov 22, 2022, 8:59 PM
Company Description
Frazier Lifesciences Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector.
The company was incorporated in 2020 and is based in Seattle, Washington.
Frazier Lifesciences Acquisition Corporation
| Country | United States |
| IPO Date | Dec 9, 2020 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | n/a |
Advertisement
Contact Details
Address: Two Union Square Seattle, Washington United States | |
| Website | https://www.frazierlifesciencesacquisition.com |
Stock Details
| Ticker Symbol | FLACU |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001828326 |
| CUSIP Number | |
| ISIN Number | KYG3710A1215 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. James N. Topper M.D., Ph.D. | Chief Executive Officer & Chairman |
| David J. Topper | Chief Financial Officer & Director |
| Gordon Empey J.D. | Vice President & Gen. Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 02, 2022 | 15-12G | Filing |
| Dec 01, 2022 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 25, 2022 | SC 13D/A | [Amend] Filing |
| Nov 25, 2022 | 4 | Filing |
| Nov 23, 2022 | 8-K | Current Report |
| Nov 23, 2022 | 4 | Filing |
| Nov 23, 2022 | 4 | Filing |
| Nov 23, 2022 | 4 | Filing |
| Nov 23, 2022 | 4 | Filing |